Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines

dc.contributor.authorHalise Inci, Gul
dc.contributor.authorParham, Taslimi
dc.contributor.authorGülçin, İlhami
dc.contributor.authorClaudiu T., Supuran
dc.date.accessioned2019-05-17T07:27:13Z
dc.date.available2019-05-17T07:27:13Z
dc.date.created2017
dc.date.issued2017
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstract4-(3-(4-Substituted-phenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl) benzenesulfonamides (9-16) were successfully synthesized and their chemical structures were confirmed by H-1 NMR, C-13 NMR, and HRMS spectra. Carbonic anhydrase I and II inhibitory effects of the compounds were investigated. Ki values of the compounds were in the range of 316.7 +/- 9.6-533.1 +/- 187.8nM towards hCA I and 412.5 +/- 115.4-624.6 +/- 168.2nM towards hCA II isoenzymes. While K-i values of the reference compound Acetazolamide were 278.8 +/- 44.3 nM and 293.4 +/- 46.4 nM towards hCA I and hCA II izoenzymes, respectively. Compound 14 with bromine and compound 13 with fluorine substituents can be considered as the leader compounds of the series because of the lowest K-i values in series to make further detailed carbonic anhydrase inhibiton studies.
dc.identifier.doi10.1080/14756366.2016.1244533
dc.identifier.endpage192
dc.identifier.issue1
dc.identifier.startpage189
dc.identifier.urihttps://hdl.handle.net/11772/1188
dc.identifier.volume32
dc.language.isoen
dc.publisherInforma
dc.relation.ispartofJournal of Enzyme Inhibition and Medicinal Chemistry
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectCarbonic anhydrase
dc.subjectEnzyme
dc.subjectPyrazoline
dc.subjectSulfonamide
dc.titleSynthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: